Cargando…

Mapping health outcome measures from a stroke registry to EQ-5D weights

PURPOSE: To map health outcome related variables from a national register, not part of any validated instrument, with EQ-5D weights among stroke patients. METHODS: We used two cross-sectional data sets including patient characteristics, outcome variables and EQ-5D weights from the national Swedish s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghatnekar, Ola, Eriksson, Marie, Glader, Eva-Lotta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599434/ https://www.ncbi.nlm.nih.gov/pubmed/23496957 http://dx.doi.org/10.1186/1477-7525-11-34

Ejemplares similares

Effect of early supported discharge after stroke on patient reported outcome based on the Swedish Riksstroke registry
por: Bråndal, Anna, et al.
Publicado: (2019)

The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey
por: Sjölander, Maria, et al.
Publicado: (2013)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Acute stroke alert activation, emergency service use, and reperfusion therapy in Sweden
por: Eriksson, Marie, et al.
Publicado: (2017)

Time Trends and Monthly Variation in Swedish Acute Stroke Care
por: Darehed, David, et al.
Publicado: (2019)

Validity of EQ-5D-5L in stroke
por: Golicki, Dominik, et al.
Publicado: (2014)

The Importance of Integrating Clinical Relevance and Statistical Significance in the Assessment of Quality of Care –Illustrated Using the Swedish Stroke Register
por: Lindmark, Anita, et al.
Publicado: (2016)

Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
por: Aghdaee, Mona, et al.
Publicado: (2022)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

How do EQ-5D-3L and EQ-5D-5L compare in a Swedish total hip replacement population?
por: Eneqvist, Ted, et al.
Publicado: (2020)

Mapping onto Eq-5 D for patients in poor health
por: Versteegh, Matthijs M, et al.
Publicado: (2010)

Assessment of outcome measures for cost–utility analysis in depression: mapping depression scales onto the EQ-5D-5L
por: Gamst-Klaussen, Thor, et al.
Publicado: (2018)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease
por: Goldsmith, Kimberley A, et al.
Publicado: (2010)

Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures
por: Lee, Min-Sang, et al.
Publicado: (2020)

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data
por: Hernández‐Alava, Mónica, et al.
Publicado: (2022)

Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
por: Fitriana, Titi Sahidah, et al.
Publicado: (2021)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy
por: Wijnen, Ben F. M., et al.
Publicado: (2017)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial
por: Pennington, Becky M., et al.
Publicado: (2020)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
por: Olariu, Elena, et al.
Publicado: (2023)

Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database
por: Dakin, Helen
Publicado: (2013)

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
por: Wolfs, Claire AG, et al.
Publicado: (2007)

Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
por: Wille, Nora, et al.
Publicado: (2010)

Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing’s syndrome (ERCUSYN)
por: Badia, X., et al.
Publicado: (2013)

Danish population health measured by the EQ-5D-5L
por: Jensen, Morten B., et al.
Publicado: (2021)

Mapping EQ-5D-3L from the Knee Injury and Osteoarthritis Outcome Score (KOOS)
por: Kiadaliri, Ali, et al.
Publicado: (2019)

Mapping to Quality of Life and Capability Measures in Cataract Surgery Patients: From Cat-PROM5 to EQ-5D-3L, EQ-5D-5L, and ICECAP-O Using Mixture Modelling
por: Dixon, Padraig, et al.
Publicado: (2020)

Mapping the Oxford Shoulder Score onto the EQ-5D utility index
por: Valsamis, Epaminondas M., et al.
Publicado: (2022)

Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore
por: Wang, Ye, et al.
Publicado: (2015)

Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L
por: Lindkvist, Marie, et al.
Publicado: (2016)

Primary Non-Adherence to Preventive Drugs and Associations with Beliefs About Medicines in Stroke Survivors
por: Westberg, Annica, et al.
Publicado: (2022)

Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL
por: Hatswell, Anthony James, et al.
Publicado: (2016)

Mapping EQ-5D utilities to GBD 2010 and GBD 2013 disability weights: results of two pilot studies in Belgium
por: Maertens de Noordhout, C., et al.
Publicado: (2017)

EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents – a cross-sectional study
por: Åström, Mimmi, et al.
Publicado: (2020)

Comparing the EQ-5D-3 L and EQ-5D-5 L: studying measurement and scores in Indonesian type 2 diabetes mellitus patients
por: Arifin, Bustanul, et al.
Publicado: (2020)

EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
por: Jiang, Ruixuan, et al.
Publicado: (2022)

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
por: Herdman, M., et al.
Publicado: (2011)

Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
por: Ferreira, Lara N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_majl9sjlf9jnme1ltgtju7icgh